Overview
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector with 30 years of experience. The shares of BB Biotech are listed on the SIX Swiss Exchange, the Frankfurt Stock Exchange and the Stock Exchange in Milan. Its investments are focused on listed companies that are developing and commercializing novel drugs that offer sound value for the healthcare system.
BB Biotech AG is a high-conviction, fundamental and long-term investor that offers investors direct access to a select portfolio of promising, fast-growing and profitable biotech companies listed on stock markets around the world, but with a strong bias to the US.
BB Biotech aims to deliver a compound total return of at least 15% per year with an annual dividend equivalent to 5% of NAV.
We wrote a note about the company that can be found below:
- Bold Brilliant biotech investor, published 11 February 2021
You can access the company’s website here
Fundamentals
Price
Research History
-
13 Oct 2022
QuotedData’s Investment Companies Quarterly Review – Third Quarter 2022
Third quarter of 2022 Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Piling on the misery In the face of rising inflation, exacerbated by the war in Ukraine, central bankers have condemned for their relative inaction. However, in the third quarter of 2022, they stepped up a gear. Last month’s economic and political roundup […]
-
02 Nov 2021
Manager Interviews - BB Biotech AG
BB Biotech – Interview with Dr. Daniel Koller BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector with more than 25 years of experience. Dr. Daniel Koller is Head of the Investment Management Team for BB Biotech AG. He studied biochemistry […]
-
11 Feb 2021
BB Biotech AG - A leading biotech investor
A leading biotech investor BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with a […]
-
11 Feb 2021
BB Biotech AG - Bold Brilliant biotech investor
Bold Brilliant biotech investor BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with a […]
-
11 Feb 2021
BB Biotech AG - Bold Brilliant biotech investor
Bold Brilliant biotech investor Swiss-listed BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with […]
